SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028594
Filing Date
2022-08-09
Accepted
2022-08-09 08:01:07
Documents
84
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fusn-10q_20220630.htm   iXBRL 10-Q 2741656
2 EX-10.1 fusn-ex101_130.htm EX-10.1 491277
3 EX-31.1 fusn-ex311_6.htm EX-31.1 20835
4 EX-31.2 fusn-ex312_8.htm EX-31.2 20886
5 EX-32.1 fusn-ex321_7.htm EX-32.1 9388
6 EX-32.2 fusn-ex322_9.htm EX-32.2 9385
  Complete submission text file 0001564590-22-028594.txt   11706028

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA fusn-20220630.xsd EX-101.SCH 72439
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fusn-20220630_cal.xml EX-101.CAL 64161
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fusn-20220630_def.xml EX-101.DEF 182544
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fusn-20220630_lab.xml EX-101.LAB 544852
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fusn-20220630_pre.xml EX-101.PRE 391348
78 EXTRACTED XBRL INSTANCE DOCUMENT fusn-10q_20220630_htm.xml XML 2396477
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39344 | Film No.: 221146473
SIC: 2836 Biological Products, (No Diagnostic Substances)